Biofrontera AG (B8FK) Stock Price & News

All values in EUR	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	3.55M	-	3.71M	5.32M
Cost of goods sold	1.15M	-	709.00K	1.01M
Cost of revenue	1.15M	-	709.00K	1.01M
Research and development expenses	1.20M	-	539.00K	601.00K
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	2.20M	-	2.46M	2.28M
Operating expense	3.40M	-	3.00M	2.89M
Total operating expenses	4.56M	-	3.70M	3.89M
Operating income	-1.00M	-	9.00K	1.43M
Other non operating income	540.00K	-	38.00K	37.00K
EBT including unusual items	-369.00K	-	41.00K	1.47M
EBT excluding unusual items	-369.00K	-	41.00K	1.47M
Income tax expense	1.00K	-	-	4.00K
Effective tax rate	-0.27%	-	-	0.27%
Other operating expenses	-	-	-	-
Net income	-370.00K	-	2.20M	3.33M
Net profit margin	-10.41%	-	59.24%	62.60%
Earnings per share	-	-	-	-
Interest and investment income	-	-	-	6.00K
Interest expense	-1.00K	-	-6.00K	-
Net interest expenses	-1.00K	-	-6.00K	6.00K
Depreciation and amortization charges	-	-	-	-
EBITDA	-940.50K	-	54.75K	1.54M
Gain or loss from assets sale	-	-	-	-

Finance